Dunbar Erin M, Buzzeo Mathew P, Levine Jeff B, Schold Jesse D, Meier-Kriesche Herwig-Ulf, Reddy Vijay
Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Haematologica. 2008 Dec;93(12):1852-8. doi: 10.3324/haematol.13033. Epub 2008 Oct 22.
Natural killer cells are known to have anti-tumor activity in haploidentical hematopoietic stem cell transplantation. We hypothesized that reconstituted circulating natural killer cells may be associated with improved relapse-free survival after HLA-matched hematopoietic stem cell transplantation.
Serial peripheral blood absolute natural killer cell counts were prospectively measured by flow cytometry of lymphocytes expressing CD56 and CD16 in 167 patients. Cluster analysis was used at engraftment and 60 days post-transplant to distinguish patients with high and low absolute natural killer cell counts. At engraftment 80 patients had high counts (> 22.2/mm3) and 43 had low counts. At 60 days post-transplant 84 patients had high counts (> 18.2/mm3) and 38 had low counts. The primary study end-points were death, relapse and acute graft-versus-host disease. The median follow-up was 373 days (range, 67-1767).
Among patients given reduced intensity conditioning, a low absolute natural killer cell count at 60 days post-transplant was independently associated with relapse [adjusted hazard ratio (AHR) = 28.4, 95% confidence interval (CI) 4.3-186.4] and death (AHR = 17.5, 95% CI 4.3-71.3). Furthermore, patients given reduced intensity conditioning who had a high absolute natural killer cell count at 60 days had a significantly better 1-year survival than those with a low count by Kaplan-Meier analysis (83% vs. 11%, p<0.001). Multivariate analysis confirmed that low 60-day absolute natural killer count in patients given reduced intensity conditioning was independently associated with an increase in relapse or death (AHR = 20.22, 95% CI 4.76-85.40). In contrast, there was no significant association between 60-day absolute natural killer cell counts and clinical outcomes in patients receiving myeloablative conditioning. There was no significant association between absolute natural killer cell count and graft-versus-host disease.
High natural killer cell reconstitution is associated with reduced relapse and death without an increased incidence of graft-versus-host-disease after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Measuring reconstituted natural killer cells expressing CD56(+)/CD16(+) post-transplant may have novel prognostic and therapeutic implications.
已知自然杀伤细胞在单倍体造血干细胞移植中具有抗肿瘤活性。我们推测,在人类白细胞抗原(HLA)匹配的造血干细胞移植后,重建的循环自然杀伤细胞可能与无复发生存期的改善有关。
通过流式细胞术对167例患者淋巴细胞中表达CD56和CD16的细胞进行检测,前瞻性地测定系列外周血自然杀伤细胞绝对计数。在植入时和移植后60天进行聚类分析,以区分自然杀伤细胞绝对计数高和低的患者。植入时,80例患者计数高(>22.2/mm³),43例患者计数低。移植后60天,84例患者计数高(>18.2/mm³),38例患者计数低。主要研究终点为死亡、复发和急性移植物抗宿主病。中位随访时间为373天(范围67 - 1767天)。
在接受减低强度预处理的患者中,移植后60天自然杀伤细胞绝对计数低与复发[校正风险比(AHR)=28.4,95%置信区间(CI)4.3 - 186.4]和死亡(AHR = 17.5,95%CI 4.3 - 71.3)独立相关。此外,通过Kaplan-Meier分析,移植后60天自然杀伤细胞绝对计数高的接受减低强度预处理患者1年生存率显著高于计数低的患者(83%对11%,p<0.001)。多变量分析证实,接受减低强度预处理患者移植后60天自然杀伤细胞绝对计数低与复发或死亡增加独立相关(AHR = 20.22,95%CI 4.76 - 85.40)。相比之下,接受清髓性预处理患者的移植后60天自然杀伤细胞绝对计数与临床结局之间无显著关联。自然杀伤细胞绝对计数与移植物抗宿主病之间无显著关联。
在减低强度预处理的异基因造血干细胞移植后,高自然杀伤细胞重建与复发和死亡减少相关,且移植物抗宿主病发生率未增加。移植后检测表达CD56(+)/CD16(+)的重建自然杀伤细胞可能具有新的预后和治疗意义。